Market Place
Sourcing Support
Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination
The pharmaceutical industry has long recognized the critical role
excipients or inactive ingredient
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Will a Spanish drug, retailing for under 10 euros, get sold in the U.S. for $89,000/year?
On
February 9, 2017 Marathon Pharmaceuticals LLC received FDA approval for Emflaza
(deflazacort), ta
